
Peptilex โ The Peptide Encyclopedia
- 34 peptides โ from semaglutide to BPC-157 โ in one book
- An evidence grade (AโE) and the key studies for every peptide
- Where each one stands in 2026 โ US, EU and Switzerland

Every profile has its own page on this site.
ยน Highest-level treatment group. Different trials, durations and populations โ not a head-to-head comparison.
Sources: TRIUMPH-1 ยท NEJM 2026 ยท SURMOUNT-1 ยท NEJM 2022 ยท REDEFINE 1 ยท NEJM 2025 ยท STEP 1 ยท NEJM 2021
| Average weight loss in landmark trials | Trial | Treatment | Placebo |
|---|---|---|---|
| Retatrutide | TRIUMPH-1 | 25.0% | 3.9% |
| Tirzepatide | SURMOUNT-1 | 20.9% | 3.1% |
| CagriSema | REDEFINE 1 | 20.4% | 3.0% |
| Semaglutide | STEP 1 | 14.9% | 2.4% |
| GLP-1 | GIP | Glucagon | Amylin | |
|---|---|---|---|---|
| Liraglutide1ร | ||||
| Semaglutide1ร | ||||
| Tirzepatide2ร | ||||
| Retatrutide3ร | ||||
| CagriSema2ร |
Source: Peptilex 1, profile overview (type of each peptide)
No. Peptilex explains research for education. Talk to a doctor before any health decision.
Kindle for instant reading on any device; paperback or hardcover if you like to mark pages โ the content is the same.
The book reflects the research as of September 2026. The free study tracker on this site follows new studies every week.

